新型コロナ感染症 ファイザー、ワクチン最終分析で有効性95％と発表（写真:ロイター/アフロ） [ロンドン発]米製薬大手 ...
The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...
Since the announcements by federal health authorities earlier this year that federal mRNA vaccine funding will be curtailed, a fierce debate has taken place around the future of mRNA-based vaccines ...
[The content of this article has been produced by our advertising partner.] Since their emergency-use rollout in late 2020, billions of doses of COVID 19 vaccines built on disruptive mRNA technology ...
The U.S. Food and Drug Administration is refusing to consider a new mRNA flu vaccine made by Moderna, the company revealed in a statement on Tuesday. The vaccine uses mRNA to inoculate the ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する